Karen Madden

Karen Madden

Director/Board Member at JOHN WILEY & SONS, INC.

Net worth: - $ as of 31/05/2026

57 year
Consumer Services
Commercial Services
Health Technology

Profile

Dr. Karen N.
Madden
is an Independent Director at John Wiley & Sons, Inc., a Head-Canada Life Science Business at Merck KGaA and a Chief Technology Officer & Senior Vice President at EMD Millipore Corp.
She is on the Board of Directors at John Wiley & Sons, Inc., Analytical Life Science & Diagnostics Association, Greater Boston Chamber of Commerce and The New England Council, Inc. Dr. Madden was previously employed as a Principal by SGX Pharmaceuticals, Inc. and a SVP-Corporate Development & External Research by VisEn Medical, Inc. She received her undergraduate degree from Boston University, a graduate degree from the University of Pennsylvania and a doctorate degree from Rutgers State University of New Jersey.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
23/04/2026 0 ( -.--% ) - $ 31/05/2026

Karen Madden active positions

CompaniesPositionStart
JOHN WILEY & SONS, INC. Director/Board Member 28/02/2025
MERCK KGAA Corporate Officer/Principal 01/01/2022
Chief Tech/Sci/R&D Officer -
Director/Board Member -
Director/Board Member -
Analytical Life Science & Diagnostics Association
Director/Board Member -

Former positions of Karen Madden

CompaniesPositionEnd
Corporate Officer/Principal 26/07/2013
Corporate Officer/Principal -
See the detail of Karen Madden's experience

Training of Karen Madden

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

89

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Commercial Services

Consumer Services

Health Technology

Health Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Commercial Services

Analytical Life Science & Diagnostics Association

Commercial Services

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!